Intelligence · Clinical Pipeline
Sanofi-Aventis U.S Pipeline
All ClinicalTrials.gov programs at Sanofi-Aventis U.S — phase, modality, and trial IDs.
- Programs
- 14
Quick answer
Sanofi-Aventis U.S has 14 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
A Phase 1 first-in-human study to evaluate SAR447754 in healthy adult participants and in adult participants with moderate-to-severe atopic dermatitis.
Sanofi-aventis Healthcare Pty Ltd
Dermatitis atopic
1 trial -
A first-in-human study to investigate safety and tolerability of SAR446959 in participants with osteoarthritis of the knee
Sanofi-aventis Healthcare Pty Ltd
Osteoarthritis
1 trial -
A study to investigate a potential effect of rilzabrutinib (SAR444671) on ethinylestradiol and levonorgestrel from combined oral contraceptives in healthy female participants
Sanofi-aventis Healthcare Pty Ltd
Immune Thrombocytopenia Purpura
1 trial -
A study to investigate how different tablet types of balinatunfib and food will influence the absorption of balinatunfib in blood in healthy adult participants
Sanofi-aventis Healthcare Pty Ltd
Immune system diseases
1 trial -
A study to investigate immune challenge induced skin reactions with SAR445399, canakinumab and spesolimab compared with placebo, in healthy participants aged 18 to 55 years
Sanofi-aventis Healthcare Pty Ltd
Immuun system diseases
1 trial -
A study to investigate the bioavailability of the SAR444656 test formulation and the food effect on the SAR444656 test formulation in healthy adult participants
Sanofi-aventis Healthcare Pty Ltd
Healthy Volunteer
1 trial -
A study to investigate the pharmacokinetics and safety of a single dose of duvakitug in healthy adult participants
Sanofi-aventis Healthcare Pty Ltd
Healthy Volunteers
1 trial -
A study to investigate the safety and efficacy of SAR446523 injected subcutaneously in adult participants with relapsed/refractory myeloma
Sanofi-aventis Healthcare Pty Ltd
Plasma cell myeloma refractory
1 trial -
A study to test a medicine (fitusiran) for preventing bleeds in people with severe hemophilia who previously received preventive treatment with emicizumab
Sanofi-aventis Healthcare Pty Ltd
Hemophilia A
1 trial -
An open-label, DDI study to investigate the effects of amlitelimab on the PK of selected cytochrome P450 substrates
Sanofi-aventis Healthcare Pty Ltd
Dermatitis atopic
1 trial -
Effect of SAR445611 on inflammatory responses following LPS challenge study in healthy participants
Sanofi-aventis Healthcare Pty Ltd
Immune system diseases
1 trial -
Phase 1 study on SAR443122 bioavailability and food effect in healthy adults
Sanofi-aventis Healthcare Pty Ltd
Colitis ulcerative
1 trial -
SAR447971 first-in-human study
Sanofi-aventis Healthcare Pty Ltd
Hidradenitis
1 trial -
Safety and tolerability of single and multiple ascending doses of lunsekimig (SAR443765) in healthy participants
Sanofi-aventis Healthcare Pty Ltd
Asthma
1 trial
Frequently asked questions
How many pipeline programs does Sanofi-Aventis U.S have?
14 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs